Amgen’s focus on blood cell medications continued in the 2000s, with the approval of Aranesp for the treatment of anaemic patients with chronic renal failure, and the 2002 approval of Neulasta ...

First set up in the 1980s, the alliance led to former Amgen blockbusters like red blood cell stimulator Epogen (epoetin alfa) and Neulasta (filgrastim) for low white blood cell counts caused by ...

Editorial Note: We earn a commission from partner links on Forbes Advisor. Commissions do not affect our editors' opinions or evaluations. I know starting a blog seems like an easy side hustle ...

Leukopenia is when you have an abnormally low number of white blood cells (leukocytes). A low white blood cell count may or may not cause symptoms, but can result in serious health complications since ...

DiveWire guarantees visibility for your news announcements through instant distribution to BioPharma Dive’s audience and its 176,000 newsletter subscribers for 21 days.